AIX has a beta of -0.15, suggesting that its stock price is 115% less volatile than the S&P 500. Comparatively, AIX’s peers have a beta of 1.49, suggesting that their average stock price is 49% ...

13.2% of U Power shares are owned by institutional investors. Comparatively, 92.4% of Adient shares are owned by institutional investors. 0.7% of Adient shares are owned by company insiders.

Previously, Ed held various Chief Commercial and Operations Officer roles at Humanigen, DBV Technologies, AMAG Pharmaceuticals, Teva Pharmaceuticals, and Merck (Schering-Plough). He received dual ...